Archive for October, 2015

Right Turn: Boldly going where no one has gone before

Author: Stacey Johnson, 10/30/15

More than 450 people were in Toronto, Canada, this week to attend the 2015 Till & McCulloch Meetings. As you would expect from Canada’s premier stem cell conference, there was great science, interesting debates, multiple awards, talks by industry and lots of valuable networking. I did my best to follow some of the basic science…Read more

Update from the Clinic: September

Author: Mark Curtis, 10/27/15

Welcome to your Update from the Clinic for the month of September. OncoSec Medical released some initial data from its Phase 1/2 study investigating ImmunoPulse IL-12 DNA in a rare skin cancer. Pluristem and the National Institute of Allergy and Infectious Diseases (NIAID) have agreed upon a trial design for Pluristem’s Phase 2 study investigating…Read more

Right Turn: Stem cell flash mobs and old favourites

Author: Stacey Johnson, 10/23/15

If you are a loyal reader of Right Turn (thank you!) then you will know that I scour the Internet looking for unique, thought-provoking, clever, peculiar (with a mega star thrown in to the mix), educational, funny, odd, intriguing – I could go on – items to feature. And let’s not forget all the excellent…Read more

Studying the brain needs an “open mind”

Author: Hamideh Emrani, 10/21/15

Another in the series: “What Drives Research in the Field of Biomaterials?” The amazingly complex system of the brain, and its network of many different cell types interacting and functioning together, has always been “top of mind” – pardon the pun – for many researchers. It is just a little over 10 years since Professor…Read more

Cell Therapy Deal Review: September

Author: Mark Curtis, 10/20/15

. Welcome to your Cell Therapy Deal Review for the month of September. Aduro Biotech went the way of Juno and Kite and bought an antibody discovery platform. Intrexon and ZIOPHARM entered into an agreement to develop a novel Treg-based immunotherapy for GvHD. Kite Pharma expanded its relationship with the Netherlands Cancer Institute to develop…Read more

Right Turn: Sparking STEM cells interest at Super Cells

Author: Erin Sugar, 10/16/15

. Walking through the doors of MaRS Discovery District’s Phase II building in Toronto, Canada brings visitors face to face with Super Cells: The Power of Stem Cells, a free, award-winning exhibition with the purpose of educating children and teens, ages 4-14, about stem cells, the process of scientific research and aspects of working in…Read more

CRISPR/Cas9 gene editing: Is truth becoming stranger than fiction?

Author: Nicole Forgione, 10/15/15

Last week, a Nature News article reported that the Harvard geneticist George Church had modified over 60 genes in pig embryos using CRISPR/Cas9 gene editing. I’m sure you’re expecting my scientific perspective on the significance of this news in the context of the excitement and controversy over CRISPR-Cas9 gene editing—and I will discuss that here….Read more

Right Turn: What we can learn from a dancing doctor

Author: Erin Sugar, 10/09/15

. When he’s not roaming hospital corridors, Dr. Adnan Khera, an anesthesiology resident at Boston’s Tufts Medical Center, can be found dancing on the city streets two nights a week. But he’s not dancing for fame, he’s earning money for his charity “Doctor Be Dancing” which has raised more than $5,000 for several charities over…Read more

First gene therapy prescribed: How can we ensure there are more in the future?

Author: James Smith, 10/06/15

. With contributions from blogger David Brindley September 2015 has been an historic month for regenerative medicine. For the first time ever in the Western world, a prescription has been issued for a gene therapy, Glybera. At the ESGCT and FSGT Collaborative Congress, Helsinki, this news was welcomed and spurred discussion on broader challenges in…Read more

Right Turn: Turning the brain on and off with optogenetics

Author: Hamideh Emrani, 10/02/15

. So many of today’s biomedical advances are only possible because of a step forward in basic science research that happened many years ago. Basic science, be it biology, math or physics, always tries to advance our knowledge of the universe around us. It doesn’t promise to develop drugs or cure disease, but sometimes leads…Read more